We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

The Collaborative Neuropsychological Study of Polydrug Users

Igor Grant, MD; Kenneth M. Adams, PhD; Albert S. Carlin, PhD; Phillip M. Rennick, PhD; Lewis L. Judd, MD; Kenneth Schooff, MD
Arch Gen Psychiatry. 1978;35(9):1063-1074. doi:10.1001/archpsyc.1978.01770330037003.
Text Size: A A A
Published online


• A controlled three-month prospective collaborative investigation involving eight National Institute on Drug Abusesupported polydrug units was carried out. Clinical review of test protocols assessed 37% of polydrug users, 26% of psychiatric patients, and 8% of nonpatients as impaired on the Halstead-Reitan Battery. Impairment in test performance was related to increasing age, educational deprivation, and premorbid medical factors in all groups, extensive use of CNS depressants and opiates among polydrug users, and extensive use of antipsychotic drugs in psychiatric patients. Both language-related and perceptuomotor neuropsychological test deficits were found in polydrug users, but only the latter in psychiatric patients. At three-month follow-up 34% of polydrug users, 27% of psychiatric patients, and 4% of nonpatients were impaired in these test performances. Recent drug-taking (polydrug group) and schizophrenia diagnosis (psychiatric patients) were additional correlates of test impairment. Persistence of performance deficit in polydrug users raises the possibility that CNS depressants and opiates may have longer-term, slowly reversible, or even permanent effects on neuropsychological tests. The same possibility exists for antipsychotic drugs. The link of these test deficits to other specific neuropsychological functions, to performance in life situations generally, or to specific brain dysfunction, as well as the basis for a lack of test impairments in the majority of polydrug subjects remain to be determined.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.